Caricamento...

Ki-67 (30-9) scoring and differentiation of Luminal A- and Luminal B-like breast cancer subtypes

INTRODUCTION: Ki-67 labeling index assessed by immunohistochemical assays has been shown useful in assessing the risk of recurrence for estrogen receptor (ER)-positive HER2-negative breast cancers (BC) and distinguishing Luminal A-like from Luminal B-like tumors. We aimed to assess the performance o...

Descrizione completa

Salvato in:
Dettagli Bibliografici
Pubblicato in:Breast Cancer Res Treat
Autori principali: Viale, Giuseppe, Hanlon Newell, Amy E., Walker, Espen, Harlow, Greg, Bai, Isaac, Russo, Leila, Dell’Orto, Patrizia, Maisonneuve, Patrick
Natura: Artigo
Lingua:Inglês
Pubblicazione: Springer US 2019
Soggetti:
Accesso online:https://ncbi.nlm.nih.gov/pmc/articles/PMC6797656/
https://ncbi.nlm.nih.gov/pubmed/31422497
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1007/s10549-019-05402-w
Tags: Aggiungi Tag
Nessun Tag, puoi essere il primo ad aggiungerne! !